Stomach cancer natural history, complications and prognosis
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]
Stomach cancer Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Stomach cancer natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Stomach cancer natural history, complications and prognosis |
FDA on Stomach cancer natural history, complications and prognosis |
CDC on Stomach cancer natural history, complications and prognosis |
Stomach cancer natural history, complications and prognosis in the news |
Blogs on Stomach cancer natural history, complications and prognosis |
Risk calculators and risk factors for Stomach cancer natural history, complications and prognosis |
Overview
Depending on the extent of the tumor at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as poor.
Natural History
Metastasis occurs in 80-90% of individuals with stomach cancer.
Complications
- Ascites
- Gastrointestinal bleeding
- Spread of cancer to other organs or tissues
- Weight loss
Prognosis
5-Year Survival
- Between 2004 and 2010, the 5-year relative survival of patients with stomach cancer was 29%.[1]
- When stratified by age, the 5-year relative survival of patients with stomach cancer was 31.4% and 26% for patients <65 and ≥ 65 years of age respectively.[1]
- The survival of patients with stomach cancer varies with the stage of the disease. Shown below is a table depicting the 5-year relative survival by the stage of stomach cancer:[1]
Stage | 5-year relative survival (%), (2004-2010) |
All stages | 28.3% |
Localized | 64.1% |
Regional | 28.8% |
Distant | 4.2% |
Unstaged | 20.2% |
- Shown below is an image depicting the 5-year conditional relative survival (probability of surviving in the next 5-years given the cohort has already survived 0, 1, 3 years) between 1998 and 2010 of stomach cancer by stage at diagnosis according to SEER. These graphs are adapted from SEER: The Surveillance, Epidemiology, and End Results Program of the National Cancer Institute.[1]
References
- ↑ 1.0 1.1 1.2 1.3 Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z,Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975-2011, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2011/, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.